3

Click here to load reader

Solid State Capabilities

  • Upload
    ejmckee

  • View
    225

  • Download
    0

Embed Size (px)

Citation preview

Page 1: Solid State Capabilities

Solid State ServicesSupporting the development of APIs from invention to launch

API Services &Chemical Developmentwww.almacgroup.com

> Polymorph Studies

> Physical Form Screening & Selection

> Crystallisation Development

> Troubleshooting

> Physical Form Characterisation

> Analytical Method Development & Validation

> Counterfeit Analysis

> Scientific Litigation & Prosecution Support

> Inhalation Services

> Preformulation Support

Page 2: Solid State Capabilities

Biom

arke

r D

isco

very

& D

evel

opm

ent

AP

I Ser

vice

s &

Chem

ical

Dev

elop

men

t

Phar

mac

eutic

al D

evel

opm

ent

An

alyt

ical

Ser

vice

s

Clin

ical

Tri

al S

uppl

y

Clin

ical

Tec

hnol

ogie

s

Com

mer

cial

Ser

vice

s

Almac has served the global pharmaceutical industry for over 30 years in discovery, process development, manufacturing, formulation and clinical services, offering the most comprehensive range of integrated drug development services. We can utilise over 300 highly skilled scientists who are organic chemists, solid state chemists, analysts, and formulation scientists, operating in state of the art facilities. Our expertise, built from a large volume of diverse projects, puts us in a unique position to provide expert witnessing services to pharma litigation cases as a testifying or non-testifying witness. We provide services to both infringement and Paragraph IV cases.

We provide technical expertise to assist in successful patent prosecution. This service includes technical consultancy for IP and technical support for successful prosecution to overcome rejections and oppositions.

Supporting the development of APIs from invention to launch

Almac’s Physical Sciences Group has extensive experience of API development, our comprehensive range of solid state services and know-how will help strengthen the success of your product. Our solid form investigations are driven by science not robotics, with highly trained chemists and analysts directing the studies. These scientists have the ability to solve virtually any problem presented to them. They know that finding and consistently producing the drug in its optimal physical form is vital to the success of your drug development programme.

Solid State Services Scientific Litigation and Prosecution SupportProviding expertise in Pharmaceutical IP from expert witnessing to prosecution support

Expert Witness Services

Infringement support> Laboratory testing of API & drug product> API solid form analysis in the drug product> Reverse engineering of drug products> Strategy development> Expert report> Expert witnessing

Paragraph IV litigation support> ANDA reproduction of API & drug product> Laboratory testing of API & drug product> Strategy development> Expert report> Expert witnessing

IP Support Services

Intellectual Property Support > Technical consultancy> Laboratory testing to strengthen the patent

Patent Application & Prosecution> Prior art reproduction> Reproduction of specifications & examples

Patent Opposition Support> Laboratory testing> EPO hearing

Polymorph> Screening> Selection> Stable form determination

Physical Form Screen & Selection> Salt, cocrystal & amorphous screens> Selection of optimum form for development> Reproducible solid form of the API

Troubleshooting: API Issues > Crystallinity, solubility, stability, purification & yield> Batch to batch variation> Scale up problems

Drug Product Issues> Dissolution> Stability

Crystal Engineering> Crystal modification

Crystallisation Development> Process development, scale-up

Characterisation> Drug substance> Drug product

Routine Analyses> Lot release> GMP compliant

Analytical Method Development & Validation> Lot release & regulatory compliance

Counterfeit Analysis> Impurity profile> API solid form analysis in the drug product> Reverse engineering of drug products

Inhalation Services> Particle engineering> Cocrystals> Micronisation> Amorphous content & control> Moisture content & hygroscopicity

Page 3: Solid State Capabilities

Biom

arke

r D

isco

very

& D

evel

opm

ent

AP

I Ser

vice

s &

Chem

ical

Dev

elop

men

t

Phar

mac

eutic

al D

evel

opm

ent

An

alyt

ical

Ser

vice

s

Clin

ical

Tri

al S

uppl

y

Clin

ical

Tec

hnol

ogie

s

Com

mer

cial

Ser

vice

s

Our preformulation studies are designed to identify and select the optimal physical form of your API. We know that by possessing a thorough understanding of the properties of your drug substance, we can reduce the number of problems in development, lower development costs and decrease development time.

Preformulation ServicesDesign and development capability for small molecules and biologics

Determining & assessing the solid state properties> Crystallinity> Hygroscopicity> Particle size, shape & surface area> Moisture/solvent content Solid state stabilitySolution state stability Plasma stability Biopharmaceutical profiling> pH-solubility profile & pKa determination> Permeability & BCS classification > Solubility in pharmaceutical solvents> Solubility in physiological buffers

Animal formulation development> pH modifications> Cosolvents> Surfactants> Cyclodextrin inclusion complexes> Lipid based formulations

Clinical formulation> Micronised powders/suspensions> Solid/waxy dispersions> Lipid based formulations> Drug in capsule/bottle

Peptide structural characterisation> LC-MS> Absorption & fluorescence spectroscopy> Circular dichroism spectroscopy> NMR

Peptide chemical stability> Solution state chemical stability to acid, base, oxidising media, light & elevated temperatures> Solid state chemical stability to light, humidity & temperature

Formulation development studies> Effect of pH> Buffer concentration & buffer type> Surfactants> Complexing agents> Polymers & cosolvents

Compatibility & stability studies> In a range of containers & closures; assessed for peptide adsorption, compatibility, glass leachates & particulate formation.

Other parameters assessed:> Osmolarity > Viscosity> pH> Appearance> Needle flowability> Identification of impurities during stress studies

For European Enquiries:AlmacSciencesAlmac House20 Seagoe Industrial Estate, Craigavon, BT63 5QD, United Kingdom.T: +44 (0) 28 3833 2200E: [email protected]

For American Enquiries:Almac Group Incorporated25 Fretz RoadSouderton, PA 18964United States of AmericaT +1 (215) 660 8500 E: [email protected]

www.almacgroup.com